Purchase one-time access:Academic and Personal
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Differential diagnosis of axillary masses.Tumori. 1996; 82: 596-599
- Bronchopulmonary neuroendocrine tumors.Cancer. 2008; 113: 5-21
- Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination.Pharmacotherapy. 2008; 28: 1194-1197
- Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine.Clin Nucl Med. 2011; 36: 848-853
- A practical approach to imaging the axilla.Insights Imaging. 2015; 6: 217-229
- Unexplained lymphadenopathy: evaluation and differential diagnosis.Am Fam Physician. 2016; 94: 896-903
- Local reactions, systemic reactions, adverse events, and serious adverse events: Pfizer-BioNTech COVID-19 vaccine. Centers for Disease Control and Prevention, Centers for Disease Control and Prevention.www.cdc.gov/vaccines/ covid-19/info-by-product/pfizer/reactogenicity.htmlDate accessed: December 13, 2020
- Management of unilateral axillary lymphadenopathy detected on breast MRI in the era of coronavirus disease (COVID-19) vaccination [Published online ahead of print February 5, 2021].AJR Am J Roentgenol. 2021; https://doi.org/10.2214/AJR.21.25604
- Unilateral axillary adenopathy in the setting of COVID-19 vaccine.Clin Imaging. 2021; 75: 12-15
DISCLAIMER: The authors are military service members or employees of the U.S. Government. This work was prepared as part of official duties. Title 17, U.S.C. §105 provides that copyright protection under this title is not available for any work of the U.S. Government. Title 17, U.S.C. §101 defines a U.S. Government work as work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government.